Salman Razvi

Summary

Affiliation: Queen Elizabeth Hospital
Country: UK

Publications

  1. ncbi Health status in patients with sub-clinical hypothyroidism
    Salman Razvi
    Department of Diabetes and Endocrinology, Queen Elizabeth Hospital, Gateshead NE9 6SX, UK
    Eur J Endocrinol 152:713-7. 2005
  2. ncbi The incidence of ischemic heart disease and mortality in people with subclinical hypothyroidism: reanalysis of the Whickham Survey cohort
    Salman Razvi
    Department of Endocrinology, Gateshead Health National Health Service Foundation Trust, Gateshead NE9 6SX, United Kingdom
    J Clin Endocrinol Metab 95:1734-40. 2010
  3. ncbi The influence of age on the relationship between subclinical hypothyroidism and ischemic heart disease: a metaanalysis
    Salman Razvi
    Department of Endocrinology, Queen Elizabeth Hospital, Gateshead, NE9 6SX, United Kingdom
    J Clin Endocrinol Metab 93:2998-3007. 2008
  4. ncbi Subclinical thyroid disorders: significance and clinical impact
    Salman Razvi
    Department of Endocrinology, Gateshead Health NHS Foundation Trust, Gateshead, UK
    J Clin Pathol 63:379-86. 2010
  5. ncbi The beneficial effect of L-thyroxine on cardiovascular risk factors, endothelial function, and quality of life in subclinical hypothyroidism: randomized, crossover trial
    Salman Razvi
    Department of Endocrinology, Queen Elizabeth Hospital, Gateshead, United Kingdom
    J Clin Endocrinol Metab 92:1715-23. 2007
  6. ncbi Endothelial progenitor cells in subclinical hypothyroidism: the effect of thyroid hormone replacement therapy
    S K Abdul Shakoor
    Department of Endocrinology, Queen Elizabeth Hospital, Gateshead NE9 6SX, United Kingdom
    J Clin Endocrinol Metab 95:319-22. 2010
  7. ncbi Instruments used in measuring symptoms, health status and quality of life in hypothyroidism: a systematic qualitative review
    Salman Razvi
    Department of Endocrinology, Queen Elizabeth Hospital, Gateshead, UK
    Clin Endocrinol (Oxf) 63:617-24. 2005
  8. ncbi What is the evidence behind the evidence-base? The premature death of block-replace antithyroid drug regimens for Graves' disease
    Salman Razvi
    Department of Endocrinology, Royal Victoria Infirmary, Newcastle upon Tyne, UK
    Eur J Endocrinol 154:783-6. 2006
  9. ncbi Psychometric evaluation of a new questionnaire measuring treatment satisfaction in hypothyroidism: the ThyTSQ
    Carolyn McMillan
    Royal Holloway, University of London, Egham, Surrey, UK
    Value Health 9:132-9. 2006
  10. ncbi Evaluation of new measures of the impact of hypothyroidism on quality of life and symptoms: the ThyDQoL and ThySRQ
    Carolyn McMillan
    Royal Holloway, University of London, Egham, Surrey, UK
    Value Health 11:285-94. 2008

Collaborators

Detail Information

Publications10

  1. ncbi Health status in patients with sub-clinical hypothyroidism
    Salman Razvi
    Department of Diabetes and Endocrinology, Queen Elizabeth Hospital, Gateshead NE9 6SX, UK
    Eur J Endocrinol 152:713-7. 2005
    ..People with this condition may have symptoms which could affect their perception of health. Therefore, the perceived health status of people with SCH was assessed and compared with population-matched norms...
  2. ncbi The incidence of ischemic heart disease and mortality in people with subclinical hypothyroidism: reanalysis of the Whickham Survey cohort
    Salman Razvi
    Department of Endocrinology, Gateshead Health National Health Service Foundation Trust, Gateshead NE9 6SX, United Kingdom
    J Clin Endocrinol Metab 95:1734-40. 2010
    ..This result appears to be at odds with the findings of other cohort studies...
  3. ncbi The influence of age on the relationship between subclinical hypothyroidism and ischemic heart disease: a metaanalysis
    Salman Razvi
    Department of Endocrinology, Queen Elizabeth Hospital, Gateshead, NE9 6SX, United Kingdom
    J Clin Endocrinol Metab 93:2998-3007. 2008
    ..Subclinical hypothyroidism (SCH) is a common condition that has been associated with ischemic heart disease (IHD) in some, but not all, studies. This may be due to differences in study design and the characteristics of participants...
  4. ncbi Subclinical thyroid disorders: significance and clinical impact
    Salman Razvi
    Department of Endocrinology, Gateshead Health NHS Foundation Trust, Gateshead, UK
    J Clin Pathol 63:379-86. 2010
    ..The causes, effects and outcomes of treatment of both subclinical diseases are described, and the direction of future research in these conditions is outlined...
  5. ncbi The beneficial effect of L-thyroxine on cardiovascular risk factors, endothelial function, and quality of life in subclinical hypothyroidism: randomized, crossover trial
    Salman Razvi
    Department of Endocrinology, Queen Elizabeth Hospital, Gateshead, United Kingdom
    J Clin Endocrinol Metab 92:1715-23. 2007
    ..It is uncertain whether treatment of SCH with L-thyroxine improves cardiovascular (CV) risk factors and quality of life...
  6. ncbi Endothelial progenitor cells in subclinical hypothyroidism: the effect of thyroid hormone replacement therapy
    S K Abdul Shakoor
    Department of Endocrinology, Queen Elizabeth Hospital, Gateshead NE9 6SX, United Kingdom
    J Clin Endocrinol Metab 95:319-22. 2010
    ..However, its management remains controversial. Endothelial progenitor cells (EPC), expressing both endothelial and stem cell markers, are known to offer a novel CV risk marker...
  7. ncbi Instruments used in measuring symptoms, health status and quality of life in hypothyroidism: a systematic qualitative review
    Salman Razvi
    Department of Endocrinology, Queen Elizabeth Hospital, Gateshead, UK
    Clin Endocrinol (Oxf) 63:617-24. 2005
    ....
  8. ncbi What is the evidence behind the evidence-base? The premature death of block-replace antithyroid drug regimens for Graves' disease
    Salman Razvi
    Department of Endocrinology, Royal Victoria Infirmary, Newcastle upon Tyne, UK
    Eur J Endocrinol 154:783-6. 2006
    ....
  9. ncbi Psychometric evaluation of a new questionnaire measuring treatment satisfaction in hypothyroidism: the ThyTSQ
    Carolyn McMillan
    Royal Holloway, University of London, Egham, Surrey, UK
    Value Health 9:132-9. 2006
    ..It will assist health professionals in considering psychological outcomes when treating people with hypothyroidism, and is suitable for clinical trials and routine clinical monitoring...
  10. ncbi Evaluation of new measures of the impact of hypothyroidism on quality of life and symptoms: the ThyDQoL and ThySRQ
    Carolyn McMillan
    Royal Holloway, University of London, Egham, Surrey, UK
    Value Health 11:285-94. 2008
    ....